Press Releases Absci Corporation

Stocks

ABSI

US00091E1091

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:38:56 2026-06-11 pm EDT			5-day change	1st Jan Change
6.345 ^USD	-0.55%		-14.10%	+80.66%

Jun. 10	Absci Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03:20 PM
Jun. 05	Absci Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 07:35 AM

Press Releases

Jun. 10	OpenFold Consortium Adds Eleven New Members as Momentum Builds for Open AI Infrastructure in Biology and Drug Discovery	AQ
May. 20	Absci to Participate in Upcoming Investor Conferences	GL
May. 07	Absci : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
May. 07	Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results	GL
May. 07	Absci : Corporate Presentation, May 2026	PU
May. 04	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	GL
Apr. 23	Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026	GL
Apr. 08	Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference	GL
Mar. 24	Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results	GL
Mar. 24	Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic	GL
Mar. 24	Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic	AQ
Mar. 06	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	GL
Mar. 03	Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer	GL
Feb. 24	Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026	GL
Feb. 17	Absci to Participate in Upcoming Investor Conferences	GL
Dec. 16	Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference	GL
Dec. 16	Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference	AQ
Dec. 12	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave	AQ
Dec. 11	Absci : ABS-201 KOL Seminar Presentation	PU
Dec. 11	Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization	GL
Dec. 10	Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research	GL
Dec. 04	Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia	GL
Nov. 12	Absci : Corporate Presentation, Fall 2025	PU
Nov. 12	Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results	GL
25-10-29	Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025	GL